PBMI Member Newsletter - 2018 | Volume 18

PBMI Perspectives is a focused look at the latest healthcare news stories and their practical implications for prescription drug plan sponsors. Each issue features a topic with an important impact on the healthcare system, along with evidence-based, practical advice. We do the hard work of culling out good information from junk science, so you don’t have to. Browse previous newsletters.

Newsletter Topic

Copay Assistance Programs – Friend or Foe?


Most employers are aware of copay assistance programs and allow use of them for specialty medications1. These programs consist of patient financial assistance, copay cards/coupons, and copay assistance provided by drug manufacturers and nonprofit organizations. Eighty percent of employers use patient financial assistance programs according to the 2018 Trends in Specialty Drug Benefits report.

Although these programs can offer a lifeline to patients to help cover prescription costs, questions around whether they hinder the use of lower cost drugs in favor of branded drugs is a hot topic of debate.

The use of copay accumulators has been adopted by many plan sponsors to help ensure that the drug benefit cost-sharing is applied as planned and to help manage plan costs. What level of impact will copay accumulators have on patient affordability and medication adherence? Only time will tell as this controversial aspect of drug benefit design unfolds.

Would you like to learn more about drug coupons and copay assistance programs? Check our announcements for our latest class.


1 PBMI 2018 Trends in Specialty Drug Benefits report.

Members News

Welcome PBMI's Newest Member


Contact: Robin Kahn

Email: Robin.kahn@abbvie.com

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives.  We are AbbVie, a highly focused research-driven biopharmaceutical company.

Our more than 29,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.

For more information go to www.abbvie.com

Do you have any press releases or case studies that address drug benefit challenges and related educational information that you'd like to share?  Send along to info@pbmi.com.

Magellan Rx Management Releases New Product Approvals Resource


2018 Next Generation Rx Forum


Mark your calendars for November 8th. We'll be at the San Diego Marriott La Jolla Hotel, California hosting our 2018 Next Generation Rx Forum.

September Webinars - Reserve Your Seat Today


We have two great webinars lined up for September, check them out.

PBMI 2019 National Conference


Want to showcase your work at our 2019 National Conference in Palm Springs, California? Send in a speaker submission today. The deadline is 9/14.

Specialty Rx Forum


Hurry, limited spots left for our Specialty Rx Forum - September 13 in Minneapolis. Prices go up September 3rd, register today!

No content found